Ryman Healthcare Limited
RHCGF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,763 | $3,868 | $2,806 | $4,918 |
| - Cash | $18 | $42 | $28 | $28 |
| + Debt | $1,695 | $2,569 | $2,345 | $2,590 |
| Enterprise Value | $3,440 | $6,395 | $5,122 | $7,480 |
| Revenue | $714 | $651 | $560 | $504 |
| % Growth | 9.7% | 16.1% | 11.2% | – |
| Gross Profit | $714 | -$1 | -$20 | $2 |
| % Margin | 100% | -0.2% | -3.5% | 0.4% |
| EBITDA | -$27 | -$51 | $458 | $788 |
| % Margin | -3.8% | -7.8% | 81.8% | 156.5% |
| Net Income | -$437 | $5 | $258 | $693 |
| % Margin | -61.2% | 0.7% | 46% | 137.5% |
| EPS Diluted | -0.61 | 0.007 | 0.5 | 1.31 |
| % Growth | -8,940.6% | -98.6% | -61.8% | – |
| Operating Cash Flow | $410 | $658 | $543 | $536 |
| Capital Expenditures | -$107 | -$172 | -$324 | -$299 |
| Free Cash Flow | $303 | $486 | $219 | $237 |